QbD enabled RP - HPLC method optimization and validation for estimation of bifonazole in bulk and pharmaceutical formulation
Future Journal of Pharmaceuticals and Health Sciences · 20.04.2026 · 6 (2) · 62-74
DOI: 10.26452/fjphs.v6i2.561 ↗Kurz gefasst
Fachartikel in der Zeitschrift Future Journal of Pharmaceuticals and Health Sciences, online erschienen am 20.04.2026. Verfasst von {"name":"Alamsara Kasai","email":"alamsaraqureshi49643@gmail.com","affiliation und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Bifonazole is an antifungal agent extensively utilized in the management of fungal infections and demonstrates solubility in a variety of organic solvents, including methanol and ethanol. In this investigation, a straightforward, fast, reliable, and precis e RP - HPLC technique was established and validated for quantifying Bifonazole in both active pharmaceutical ingredient (API) and solid dosage formulations. A Quality by Design (QbD) strategy was employed, incorporating Design of Experiments (DoE) to enhance chromatographic conditions. Two key variables methanol concentration in the mobile phase (% v/v) and flow rate (mL/min) were examined through 13 experimental trials, including three center points. Retention time and peak area were selected as response var iables, and analysis of variance (ANOVA) of the quadratic model was conducted to determine the significant parameters influencing method performance. Effective chromatographic separation was obtained using a C18 column (4.6 × 250 mm, 5 μm) with a mobile ph ase composed of methanol and OPA (70:30% v/v, pH 3) at a flow rate of 1.4 mL/min and a detection wavelength of 254 nm. The method demonstrated strong linearity across a concentration span of 20 – 100 μg/mL, with a correlation coefficient of 0.9988. Validatio n characteristics such as precision, accuracy, robustness, limit of detection (LOD), and limit of quantification (LOQ) complied with ICH guidelines. The %RSD was below 2%, indicating excellent precision. Accuracy assessments at 80%, 100%, and 120% levels s howed consistent recovery. The assay of the marketed formulation yielded 100 ± 1% of the labeled claim.System suitability metrics, including theoretical plates (>2000), tailing factor (
Zitieren
APA
Kasai","email":"alamsaraqureshi49643@gmail.com","affiliation, N., Marathe","email":"alamsaraqureshi49643@gmail.com","affiliati, N., Ahmed","email":"alamsaraqureshi49643@gmail.com","affiliation, N., & Khan","email":"alamsaraqureshi49643@gmail.com","affiliati, N. J. (2026). QbD enabled RP - HPLC method optimization and validation for estimation of bifonazole in bulk and pharmaceutical formulation. Future Journal of Pharmaceuticals and Health Sciences, 6(2), 62-74. https://doi.org/10.26452/fjphs.v6i2.561
Vancouver
Kasai","email":"alamsaraqureshi49643@gmail.com","affiliation N, Marathe","email":"alamsaraqureshi49643@gmail.com","affiliati N, Ahmed","email":"alamsaraqureshi49643@gmail.com","affiliation N, Khan","email":"alamsaraqureshi49643@gmail.com","affiliati NJ. QbD enabled RP - HPLC method optimization and validation for estimation of bifonazole in bulk and pharmaceutical formulation. Future Journal of Pharmaceuticals and Health Sciences. 2026;6(2):62-74. doi:10.26452/fjphs.v6i2.561
BibTeX
@article{Kasaiemailalamsaraqureshigmailcomaffiliation2026,
author = {Kasai","email":"alamsaraqureshi49643@gmail.com","affiliation, "name":"Alamsara and Marathe","email":"alamsaraqureshi49643@gmail.com","affiliati, "name":"Yamini and Ahmed","email":"alamsaraqureshi49643@gmail.com","affiliation, "name":"Aejaz and Khan","email":"alamsaraqureshi49643@gmail.com","affiliati, "name":"Gulam J.},
title = {QbD enabled RP - HPLC method optimization and validation for estimation of bifonazole in bulk and pharmaceutical formulation},
journal = {Future Journal of Pharmaceuticals and Health Sciences},
year = {2026},
volume = {6},
number = {2},
pages = {62--74},
doi = {10.26452/fjphs.v6i2.561}
}
EUVIMED